Dudediligence.

Acadia Pharmaceuticals Inc

ACADNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$1,241,177

4 notices · 52,671 sh

Oct 2025 to Oct 2026

Reported ·

$2,083,510

18 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

None of the 18 reported sales carry the 10b5-1 box. Together they are 0.05% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-08-05: Schneyer Mark C., Form 1442026-06-26: Kihara James, Form 1442026-05-26: JAMES K KIHARA, Form 1442025-11-10: James M Daly, Form 1442025-11-10: Daly James M, sold2025-11-18: Kihara James, sold2025-11-18: Schneyer Mark C., sold2026-02-09: Rhodes Jennifer J, sold2026-03-25: Rhodes Jennifer J, sold2026-03-25: Kihara James, sold2026-03-25: Owen Adams Catherine, sold2026-03-25: Thompson Elizabeth H.Z., sold2026-03-25: Schneyer Mark C., sold2026-04-07: Kihara James, sold2026-04-07: Schneyer Mark C., sold2026-05-04: Kihara James, sold2026-05-04: Schneyer Mark C., sold2026-05-26: Kihara James, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-08-05Schneyer Mark C., EVP, CHIEF FINANCIAL OFFICER$158,800
5,849 shplan 2025-05-19Form 4s on file end Jun 23144 ↗
2026-06-26Kihara James, PRINCIPAL ACCOUNTING OFFICER$297,000
11,421 shplan 2025-12-09144 ↗
Form 4, 2026-06-29: sold 11,421 at $26.08 Form 4 ↗
2026-05-26JAMES K KIHARA, PRINCIPAL ACCOUNTING OFFICER$114,394
5,401 shplan 2025-12-09144 ↗
Form 4, 2026-05-27: sold 5,401 at $21.18 Form 4 ↗
2025-11-10James M Daly, Director$670,983
30,000 shno plan date144 ↗
Form 4, 2025-11-12: sold 30,000 at $22.37 Form 4 ↗